Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar Carcinoma-Reference-Cited by-同舟云学术

Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar Carcinoma

Published:2023 Issue:3 Volume:2 Page:307-321
ISSN:2772-5723
Container-title:Gastro Hep Advances
language:en
Short-container-title:Gastro Hep Advances

Author:

Schalm Stefanie S.,O’Hearn Erin,Wilson Kevin,LaBranche Timothy P.,Silva Grace,Zhang Zhuo,DiPietro Lucian,Bifulco Neil,Woessner Richard,Stransky Nicolas,Sappal Darshan,Campbell Robert,Lobbardi Riadh,Palmer Michael,Kim Joseph,Ye Chaoyang,Dorsch Marion,Lengauer Christoph,Guzi Timothy,Kadambi Vivek,Garner Andrew,Hoeflich Klaus P.

Publisher

Elsevier BV

Reference52 articles.

1. Fibrolamellar hepatocellular carcinoma: mechanistic distinction from adult hepatocellular carcinoma;Riggle;Pediatr Blood Cancer,2016

2. Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: a detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database;Eggert;United European Gastroenterol J,2013

3. NEXAVAR (sorafenib). Prescribing Information,2018

4. Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium;Ang;Gastrointest Cancer Res,2013

5. Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma;Kaseb;Oncology,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteo-metabolomics and patient tumor slice experiments point to amino acid centrality for rewired mitochondria in fibrolamellar carcinoma;Cell Reports Medicine;2024-08